This stage of the disease is known as metastatic castrate-resistant prostate cancer (mCRPC), although earlier literature often uses the term metastatic hormone-refractory prostate cancer.

Jun 14, 2007 · Preliminary research suggests that radium-233 may prolong overall survival in patients with hormone-refractory prostate cancer who also have bone metastases.

Chemotherapy in Hormone-refractory Prostate Cancer. Studies in the past few years have highlighted the value of chemotherapy in progressive prostate cancer. In the 1990s, ...

Jan 30, 2024 · Local therapies for advanced prostate cancer were associated with significantly more gastrointestinal and sexual issues in subsequent years than systemic treatments. This site is intended for ...

Sep 26, 2007 · The experimental drug ZD4054 improved overall survival compared with placebo in a phase 2 trial in hormone-refractory prostate cancer, and large-scale phase 3 trials are now planned.

Despite such combination treatment, one man will die of hormone-refractory prostate cancer every 20 minutes in the United States alone. These sobering facts have led to extensive studies to define ...

Oct 28, 2002 · Therapy Options for Hormone-Refractory Metastatic Prostate Cancer? Zvi Symon, MD. Disclosures. October 28, 2002. Question.

Dec 6, 2024 · In 2010, the US Food and Drug Administration approved sipuleucel-T, the first therapeutic cancer vaccine, which improved overall survival in patients with hormone-refractory prostate cancer.

May 18, 2000 · In particular, which chemotherapy protocols, if any, should be considered?

Androgen deprivation is the mainstay of therapy for advanced prostate cancer, and this treatment leads to prostate-specific antigen (PSA) responses and clinical improvements in more than 90% of ...